{"id":455,"date":"2015-04-02T08:16:33","date_gmt":"2015-04-02T08:16:33","guid":{"rendered":"https:\/\/delveinsightblog.wordpress.com\/?p=455"},"modified":"2025-05-05T17:55:46","modified_gmt":"2025-05-05T12:25:46","slug":"anticoagulants-market-a-big-boom","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/anticoagulants-market-a-big-boom","title":{"rendered":"Anticoagulants Market A Big Boom"},"content":{"rendered":"<blockquote>\n<p style=\"text-align: center;\"><span style=\"color: #993366;\"><strong>Analyze Anticoagulants Market with DelveInsight<\/strong><\/span><\/p>\n<\/blockquote>\n<p style=\"text-align: justify;\">Anticoagulants are drugs that are given to prevent blood from clotting or prevent existing clots from getting larger. They can keep harmful clots from forming in heart, veins or arteries. Clots can block blood flow and cause a heart attack or stroke. Until recently, the only available oral anticoagulants were the vitamin K antagonists, such as warfarin which is an Injectable solution. In the past few years, however, the landscape has changed with the introduction of new oral anticoagulants that specifically target either factor Xa or thrombin. Rivaroxaban, dabigatran and apixaban, the oral factor Xa inhibitors, are active compounds with an oral bioavailability of more than 50%. The new oral anticoagulants have several advantages over warfarin, including pharmacology, laboratory monitoring, class effects and differentiating effects.<\/p>\n<p style=\"text-align: justify;\"><img decoding=\"async\" class=\"  wp-image-456 aligncenter\" src=\"https:\/\/delveinsightblog.files.wordpress.com\/2015\/04\/sasaqasas.png?w=300\" alt=\"SasaqaSas\" width=\"558\" height=\"520\" \/>Most drugs are recommended for Deep Vein thromboembolism (DVT) and pulmonary embolisms (PE) while the least being heparin-induced thrombocytopenia, thrombocytopenia, Peripheral vascular occlusion, Non-Q wave myocardial infarction, and disseminated intravascular coagulation. Currently there are 10 drugs and 9 drugs which are used for PE and DVT respectively.<\/p>\n<p style=\"text-align: justify;\"><img decoding=\"async\" class=\"  wp-image-457 aligncenter\" src=\"https:\/\/delveinsightblog.files.wordpress.com\/2015\/04\/marketed.png?w=300\" alt=\"mARKETED\" width=\"454\" height=\"221\" \/><\/p>\n<p style=\"text-align: justify;\"><strong>DelveInsight- Anti-coagulant Report, &#8220;Anticoagulants-Competitive Landscape, Market &amp; Pipeline Analysis, Forecasted Market Size 2015-2018&#8221;.<\/strong><\/p>\n<p style=\"text-align: justify;\">This DelveInsight report provides a thorough overview of these new oral anticoagulants, their approved indications, drug profiles, pharmacokinetic parameters and market growth, historical sales and forecasted sales of each molecule till 2018. The Report also provides the pipeline information and their drug profiles giving therapeutic analysis by route, mechanism of action and molecule type. The Report has also highlighted the two prevalent indications, Venous Thromboembolism and Atrial Fibrillation, its epidemiology segmented by geography and their current and future market. The Report has also given analysis on the basis of SWOT analysis.<\/p>\n<p>For more information on this report and Sample Pages, mail us at info@delveinsight.com<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Analyze Anticoagulants Market with DelveInsight Anticoagulants are drugs that are given to prevent blood from clotting or prevent existing clots from getting larger. They can keep harmful clots from forming in heart, veins or arteries. Clots can block blood flow and cause a heart attack or stroke. Until recently, the only available oral anticoagulants were [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[79,97,202,204,233,241,250,296,331,376,436,437,470,477,522,550,571,601,606],"industry":[17225],"therapeutic_areas":[17233],"class_list":["post-455","post","type-post","status-publish","format-standard","hentry","category-articles","tag-anticoagulants","tag-atrial-fibrillation","tag-deep-vein-thromboembolism-dvt","tag-delveinsight","tag-epidemiology-segmented-by-geography","tag-factor-xa","tag-forecasted-sales","tag-historical-sales","tag-inhibitors","tag-market-growth","tag-oral-bioavailability","tag-oral-factor-xa-inhibitors","tag-pharmacokinetic-parameters","tag-pipeline","tag-rivaroxaban","tag-swot-analysis","tag-thrombin","tag-vitamin-k-antagonists","tag-warfarin","industry-pharmaceutical","therapeutic_areas-hematological-disorders"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Anticoagulants Market A Big Boom - DelveInsight Business Research<\/title>\n<meta name=\"description\" content=\"Anticoagulants are drugs that are given to prevent blood from clotting or prevent existing clots from getting larger. Anticoagulants Market...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/anticoagulants-market-a-big-boom\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anticoagulants Market A Big Boom - DelveInsight Business Research\" \/>\n<meta property=\"og:description\" content=\"Anticoagulants are drugs that are given to prevent blood from clotting or prevent existing clots from getting larger. Anticoagulants Market...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/anticoagulants-market-a-big-boom\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-04-02T08:16:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-05T12:25:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/delveinsightblog.files.wordpress.com\/2015\/04\/sasaqasas.png?w=300\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Anticoagulants Market A Big Boom - DelveInsight Business Research","description":"Anticoagulants are drugs that are given to prevent blood from clotting or prevent existing clots from getting larger. Anticoagulants Market...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/anticoagulants-market-a-big-boom","og_locale":"en_US","og_type":"article","og_title":"Anticoagulants Market A Big Boom - DelveInsight Business Research","og_description":"Anticoagulants are drugs that are given to prevent blood from clotting or prevent existing clots from getting larger. Anticoagulants Market...","og_url":"https:\/\/www.delveinsight.com\/blog\/anticoagulants-market-a-big-boom","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2015-04-02T08:16:33+00:00","article_modified_time":"2025-05-05T12:25:46+00:00","og_image":[{"url":"https:\/\/delveinsightblog.files.wordpress.com\/2015\/04\/sasaqasas.png?w=300","type":"","width":"","height":""}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/anticoagulants-market-a-big-boom","url":"https:\/\/www.delveinsight.com\/blog\/anticoagulants-market-a-big-boom","name":"Anticoagulants Market A Big Boom - DelveInsight Business Research","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/anticoagulants-market-a-big-boom#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/anticoagulants-market-a-big-boom#primaryimage"},"thumbnailUrl":"https:\/\/delveinsightblog.files.wordpress.com\/2015\/04\/sasaqasas.png?w=300","datePublished":"2015-04-02T08:16:33+00:00","dateModified":"2025-05-05T12:25:46+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"Anticoagulants are drugs that are given to prevent blood from clotting or prevent existing clots from getting larger. Anticoagulants Market...","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/anticoagulants-market-a-big-boom"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/anticoagulants-market-a-big-boom#primaryimage","url":"https:\/\/delveinsightblog.files.wordpress.com\/2015\/04\/sasaqasas.png?w=300","contentUrl":"https:\/\/delveinsightblog.files.wordpress.com\/2015\/04\/sasaqasas.png?w=300"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":null,"coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Anticoagulants<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Atrial Fibrillation<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Deep Vein thromboembolism (DVT)<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">DelveInsight<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">epidemiology segmented by geography<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">factor Xa<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">forecasted sales<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">historical sales<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Inhibitors<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">market growth<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">oral bioavailability<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">oral factor Xa inhibitors<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">pharmacokinetic parameters<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Pipeline<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Rivaroxaban<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">SWOT ANALYSIS<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">thrombin<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">vitamin K antagonists<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">warfarin<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Anticoagulants<\/span>","<span class=\"advgb-post-tax-term\">Atrial Fibrillation<\/span>","<span class=\"advgb-post-tax-term\">Deep Vein thromboembolism (DVT)<\/span>","<span class=\"advgb-post-tax-term\">DelveInsight<\/span>","<span class=\"advgb-post-tax-term\">epidemiology segmented by geography<\/span>","<span class=\"advgb-post-tax-term\">factor Xa<\/span>","<span class=\"advgb-post-tax-term\">forecasted sales<\/span>","<span class=\"advgb-post-tax-term\">historical sales<\/span>","<span class=\"advgb-post-tax-term\">Inhibitors<\/span>","<span class=\"advgb-post-tax-term\">market growth<\/span>","<span class=\"advgb-post-tax-term\">oral bioavailability<\/span>","<span class=\"advgb-post-tax-term\">oral factor Xa inhibitors<\/span>","<span class=\"advgb-post-tax-term\">pharmacokinetic parameters<\/span>","<span class=\"advgb-post-tax-term\">Pipeline<\/span>","<span class=\"advgb-post-tax-term\">Rivaroxaban<\/span>","<span class=\"advgb-post-tax-term\">SWOT ANALYSIS<\/span>","<span class=\"advgb-post-tax-term\">thrombin<\/span>","<span class=\"advgb-post-tax-term\">vitamin K antagonists<\/span>","<span class=\"advgb-post-tax-term\">warfarin<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 11 years ago","modified":"Updated 1 year ago"},"absolute_dates":{"created":"Posted on Apr 2, 2015","modified":"Updated on May 5, 2025"},"absolute_dates_time":{"created":"Posted on Apr 2, 2015 8:16 am","modified":"Updated on May 5, 2025 5:55 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/455","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=455"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/455\/revisions"}],"predecessor-version":[{"id":31679,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/455\/revisions\/31679"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=455"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=455"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=455"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=455"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=455"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}